Shuttle Pharmaceuticals Holdings (SHPH) Accounts Payables (2021 - 2026)
Shuttle Pharmaceuticals Holdings (SHPH) posted quarterly Accounts Payables of $1.8 million for Q1 2026, up 99.55% year-over-year from $896885.0 in Q1 2025, and up 23.11% quarter-over-quarter from $1.5 million in Q4 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Accounts Payables (2021 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Accounts Payables history runs 6 years deep, the most recent figure standing at $1.8 million for Q1 2026.
- In Q1 2026, Accounts Payables rose 99.55% year-over-year to $1.8 million; the TTM figure through Mar 2026 stood at $1.8 million (up 99.55% YoY), while the FY2025 annual figure was $1.5 million, up 143.68% from the prior year.
- Accounts Payables for Q1 2026 stood at $1.8 million, up from $1.5 million in the prior quarter.
- The five-year high for Accounts Payables was $1.8 million in Q1 2026, with the low at $446.0 in Q4 2023.
- The 5-year median for Accounts Payables is $447474.0 (2023), against an average of $685430.1.
- The sharpest annual moves came in 2022 and 2024: Accounts Payables slumped 98.49% in 2022, then jumped 133666.82% in 2024.
- Shuttle Pharmaceuticals Holdings' Accounts Payables stood at $12500.0 in 2022, then plunged by 96.43% to $446.0 in 2023, then surged by 133666.82% to $596600.0 in 2024, then jumped by 143.68% to $1.5 million in 2025, then gained by 23.11% to $1.8 million in 2026.
- Business Quant data shows SHPH's Accounts Payables at $1.8 million in Q1 2026, $1.5 million in Q4 2025, and $1.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 356.00 Mn |
| 10 | Shuttle Pharmaceuticals Holdings | 1.86 Mn | 1.86 Mn | - | 1.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.79 Mn |
| Dec 31, 2025 | 1.45 Mn |
| Sep 30, 2025 | 1.47 Mn |
| Jun 30, 2025 | 1.17 Mn |
| Mar 31, 2025 | 896,885.00 |
| Dec 31, 2024 | 596,600.00 |
| Sep 30, 2024 | 1.35 Mn |
| Jun 30, 2024 | 364,891.00 |
| Mar 31, 2024 | 347,556.00 |
| Dec 31, 2023 | 446.00 |
| Sep 30, 2023 | 180,000.00 |
| Jun 30, 2023 | 88,741.00 |
| Mar 31, 2023 | 447,474.00 |
| Dec 31, 2022 | 12,500.00 |
| Sep 30, 2022 | 107,153.00 |
| Dec 31, 2021 | 828,313.00 |